Physician profile
Robert B Casper
NPI 1568469179
$1,543.22
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $131 · 2021: $407 · 2022: $165 · 2023: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $260.70 | 2021-2023 | Freestyle Libre 3 |
| Novo Nordisk INC | $193.68 | 2019-2021 | |
| Amarin Pharma, INC. | $139.00 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $121.29 | 2019-2021 | |
| Boston Scientific Corporation | $117.91 | 2019-2023 | Therasphere Administration Set |
| Astrazeneca Pharmaceuticals Lp | $116.12 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $108.87 | 2019-2021 | |
| Amgen INC. | $87.83 | 2019-2021 | |
| Lilly USA, LLC | $79.38 | 2019-2021 | |
| Abbvie INC. | $55.10 | 2021 | |
| Pfizer INC. | $50.14 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $38.03 | 2019-2021 | |
| Allergan, INC. | $31.94 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.40 | 2019 | |
| Esperion Therapeutics, INC. | $26.17 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $18.48 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $17.93 | 2019 | |
| Genentech USA, INC. | $16.37 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.83 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.21 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Casper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.